US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAIL, Inc.

38.36

-1.1300-2.86%

Post-market: 38.30-0.0600-0.16%19:58 EDT

Volume:2.10M

Turnover:81.22M

Market Cap:1.38B

PE:-0.66

High:40.88

Open:40.24

Low:36.94

Close:39.49

Loading ...

Overview Company News Filings

Stock Track | GRAIL Shares Plummet 14.90% After Hours on Q1 Revenue Miss, Despite Narrower Loss

BUZZ-Grail sinks after quarterly revenue miss

GRAIL Q1 EPS $(3.10) Beats $(4.11) Estimate, Sales $31.84M Miss $35.20M Estimate

GRAIL Q1 Net Loss Narrows, Revenue Rises; Shares Down

MT Newswires Live

Earnings Flash (GRAL) GRAIL Q1 Loss $3.10 Vs. FactSet Est. $3.99 Loss

MT Newswires Live

Stock Track | GRAIL Soars 22.53% on Positive Q1 Results and Encouraging Cancer Detection Trial Data

BRIEF-Grail Reports First Quarter 2025 Financial Results

Grail Inc: Positive Top-Line Results From Prevalent Screening Round of Nhs-Galleri Trial

THOMSON REUTERS

Grail Inc -Qtrly Revenue $31.8 Million

THOMSON REUTERS

Grail Inc: Plan to Share Registrational Data From Pathfinder 2 Study Later This Year

THOMSON REUTERS

Press Release: GRAIL Reports First Quarter 2025 Financial Results

Stock Track | GRAIL, Inc. (GRAL) Soars 5.03% in Pre-Market Ahead of Q1 Earnings Report

Stock Track | GRAIL, Inc. Soars 5.03% in Pre-Market as Investors Await Q1 Earnings Report

Calendar of U.S. Earnings Expected in the Week Ahead

BRIEF-Grail And Athenahealth Team Up To Offer Healthcare Providers Streamlined Ordering Of Grail's Galleri® Multi-Cancer Early Detection (Mced) Test

GRAIL Inc. Partners with athenahealth to Streamline Ordering of Galleri Multi-Cancer Early Detection Test

Grail and Athenahealth Team up to Offer Healthcare Providers Streamlined Ordering of Grail's Galleri® Multi-Cancer Early Detection (Mced) Test

THOMSON REUTERS

Legendary investor Bill Miller on why the worst is over for stocks, Amazon's a buy and Tesla isn't

SEC to drop investigation of Illumina’s Grail deal, Endpoints News says

CFO Aaron Freidin Reports Disposal of Common Shares in Grail Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRAL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":38.36,"timestamp":1749240000000,"preClose":39.49,"halted":0,"volume":2102823,"hourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.36,"latestTime":"19:58 EDT","volume":4157,"amount":159597.87,"timestamp":1749254286063},"delay":0,"floatShares":27396017,"shares":35973494,"eps":-58.51757,"marketStatus":"Market Closed","change":-1.13,"latestTime":"06-06 16:00:00 EDT","open":40.24,"high":40.88,"low":36.94,"amount":81217585.06776,"amplitude":0.099772,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-58.51757,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":39.49,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":39.49,"latestTime":"09:29 EDT","volume":971,"amount":38819.216716,"timestamp":1749216571005},"postHourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.36,"latestTime":"19:58 EDT","volume":4157,"amount":159597.87,"timestamp":1749254286063},"volumeRatio":1.3952439101005851,"impliedVol":0.995,"impliedVolPercentile":0.6329},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":27396017,"roa":"-11.99%","roe":"-62.22%","lyrEps":-63.539968,"volumeRatio":1.3952439101005851,"shares":35973494,"dividePrice":0,"high":40.88,"amplitude":0.099772,"preClose":39.49,"low":36.94,"week52Low":12.33,"pbRate":"0.57","psRate":"10.56","week52High":63.99,"institutionHeld":0,"latestPrice":38.36,"eps":-58.51757,"divideRate":0,"volume":2102823,"delay":0,"ttmEps":-58.51757,"open":40.24,"prevYearClose":17.85,"prevWeekClose":38.41,"prevMonthClose":38.41,"prevQuarterClose":25.54,"fiveDayClose":38.41,"twentyDayClose":36.1,"sixtyDayClose":30.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1139429754","title":"Stock Track | GRAIL Shares Plummet 14.90% After Hours on Q1 Revenue Miss, Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1139429754","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139429754?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:32","pubTimestamp":1747168354,"startTime":"0","endTime":"0","summary":"Shares of GRAIL, Inc. , a healthcare company focused on early cancer detection, plunged 14.90% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results. The sharp decline came as the company reported revenue that fell short of analysts' expectations, overshadowing a narrower-than-expected loss.Despite the revenue shortfall, GRAIL highlighted some positive developments in its earnings release. The company announced positive top-line results from the prev","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Stock Track | GRAIL Shares Plummet 14.90% After Hours on Q1 Revenue Miss, Despite Narrower Loss","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535819082","title":"BUZZ-Grail sinks after quarterly revenue miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2535819082","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535819082?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:21","pubTimestamp":1747167668,"startTime":"0","endTime":"0","summary":"BUZZ-Grail sinks after quarterly revenue miss** Shares of cancer diagnostic test maker Grail GRAL.O fall 18.8% to $34.81 in extended trading** Company's Q1 revenue of $31.8 million misses analysts' average expectation of $35.2 million, according to data compiled by LSEG ** GRAL reports quarterly loss of $3.10/shr, vs analysts' average estimate of $4.09/shr** Up to last close, stock up more than double YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL6N3RL0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"2535849570","title":"GRAIL Q1 EPS $(3.10) Beats $(4.11) Estimate, Sales $31.84M Miss $35.20M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535849570","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535849570?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:12","pubTimestamp":1747167152,"startTime":"0","endTime":"0","summary":"GRAIL (NASDAQ:GRAL) reported quarterly losses of $(3.10) per share which beat the analyst consensus estimate of $(4.11) by 24.57 percent.  The company reported quarterly sales of $31.84 million which missed the analyst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45390578/grail-q1-eps-3-10-beats-4-11-estimate-sales-31-84m-miss-35-20m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"2535208494","title":"GRAIL Q1 Net Loss Narrows, Revenue Rises; Shares Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2535208494","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535208494?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:09","pubTimestamp":1747166987,"startTime":"0","endTime":"0","summary":"GRAIL  reported Q1 net loss late Tuesday of $3.10 per diluted share, narrowing from a loss of $7.05 a year earlier.Three analysts polled by FactSet expected a loss of $3.99.Revenue for the quarter ended March 31 was $31.8 million, up from $26.7 million a year earlier. Three analysts surveyed by FactSet expected $35.2 million.Shares of the company were down more than 16% in recent after-hours activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRAL"],"gpt_icon":0},{"id":"2535084603","title":"Earnings Flash (GRAL) GRAIL Q1 Loss $3.10 Vs. FactSet Est. $3.99 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084603","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084603?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:07","pubTimestamp":1747166877,"startTime":"0","endTime":"0","summary":"Earnings Flash (GRAL) GRAIL Q1 Loss $3.10 Vs. FactSet Est. $3.99 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRAL"],"gpt_icon":0},{"id":"1179538506","title":"Stock Track | GRAIL Soars 22.53% on Positive Q1 Results and Encouraging Cancer Detection Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1179538506","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179538506?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:04","pubTimestamp":1747166693,"startTime":"0","endTime":"0","summary":"Shares of GRAIL, Inc.  surged 22.53% during intraday trading on Tuesday following the release of the company's first-quarter 2025 financial results and positive data from its cancer detection trials.GRAIL, a healthcare company focused on early cancer detection through blood testing, reported Q1 revenue of $31.8 million, representing a 19% year-over-year growth. The company's flagship product, Galleri, saw its revenue increase by 24% to $29.1 million. Despite posting a net loss of $106.2 million ","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535081296","title":"BRIEF-Grail Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535081296","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535081296?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:04","pubTimestamp":1747166646,"startTime":"0","endTime":"0","summary":"BRIEF-Grail Reports First Quarter 2025 Financial ResultsMay 13 (Reuters) - Grail Inc GRAL.O:GRAIL REPORTS FIRST QUARTER 2025 FINANCIAL RESULTSGRAIL INC: POSITIVE TOP-LINE RESULTS FROM PREVALENT SCREEN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA682FNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535819070","title":"Grail Inc: Positive Top-Line Results From Prevalent Screening Round of Nhs-Galleri Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2535819070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535819070?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:01","pubTimestamp":1747166464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA682FNF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2535081181","title":"Grail Inc -Qtrly Revenue $31.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535081181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535081181?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:01","pubTimestamp":1747166464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA682FNF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535081167","title":"Grail Inc: Plan to Share Registrational Data From Pathfinder 2 Study Later This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2535081167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535081167?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:01","pubTimestamp":1747166464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA682FNF:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535081903","title":"Press Release: GRAIL Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535081903","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535081903?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:01","pubTimestamp":1747166460,"startTime":"0","endTime":"0","summary":"Q1 U.S. Galleri Revenue Grew 22% Year-Over-Year to $28.7 Million. GRAIL Announces Positive Top-Line Results From the Prevalent Screening Round of the NHS-Galleri Trial. Cash Position of $677.9 Million Provides Runway Into 2028. MENLO PARK, Calif., May 13, 2025 /PRNewswire/ -- GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter 2025.\"We are pleased with the continued U.S. commercial growth of Galleri, with more than 37,000 Galleri tests completed in the first quarter of 2025, as well as recent steps to streamline the test ordering process and increase test access,\" said Bob Ragusa, Chief Executive Officer at GRAIL. \"We remain focused on developing the market for population scale multi-cancer early detection, advancing Galleri to unlock broad access, and cost efficiency.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4217","BK4139","BK4232","BK4084","R","PSA","BK4022","GRAL","BK4533","BK4588","CLIA","BK4585"],"gpt_icon":0},{"id":"1132276646","title":"Stock Track | GRAIL, Inc. (GRAL) Soars 5.03% in Pre-Market Ahead of Q1 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1132276646","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132276646?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:43","pubTimestamp":1747143816,"startTime":"0","endTime":"0","summary":"Shares of GRAIL, Inc.  surged 5.03% in pre-market trading on Tuesday, as investors appear optimistic ahead of the company's first-quarter earnings report scheduled for after market close. The significant uptick comes despite analysts expecting a loss for the quarter.According to the earnings calendar, GRAIL is anticipated to report a loss of $3.99 per share for Q1 2025. The pre-market rally suggests that investors may be expecting better-than-projected results or are optimistic about the company","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"1125226350","title":"Stock Track | GRAIL, Inc. Soars 5.03% in Pre-Market as Investors Await Q1 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1125226350","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125226350?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:43","pubTimestamp":1747143808,"startTime":"0","endTime":"0","summary":"Shares of GRAIL, Inc.  are surging 5.03% in Tuesday's pre-market trading session, as investors eagerly anticipate the company's first-quarter earnings report scheduled for release after the market close. The biotechnology company, known for its innovative cancer detection technologies, has captured the attention of Wall Street ahead of its financial disclosure.According to FactSet Research Systems Inc., analysts expect GRAIL to report a loss of $3.99 per share for the quarter. Despite the projec","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | GRAIL, Inc. Soars 5.03% in Pre-Market as Investors Await Q1 Earnings Report","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535746391","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2535746391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535746391?lang=en_us&edition=fundamental","pubTime":"2025-05-13 18:00","pubTimestamp":1747130400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·a.k.a. Brands Hldg                               1Q      (.82)  4:05 PM. ·Anavex Lf Scncs                                 2Q      (.15)  7:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DARE","VRCA","BODI","ZVRA","CAE","OLMA","BOOT","IGT","WALD","JD","CUE","GAUZ","UA","ALLO","VXRT","NYAX","LEGN","TWFG","SSTI","ECG","LOAR","INO","PERI","GEVO","FLOC","AIOT","ONON","EXEL","CELC","OMER","TEO","GWH","KLC","CAMT","PXLW","CLRB","LOOP","GRAL","DRUG","SE","SMWB","JANX","RNA","QUIK","INZY","NUTX","MDAI","ADCT","AFCG"],"gpt_icon":1},{"id":"2535781969","title":"BRIEF-Grail And Athenahealth Team Up To Offer Healthcare Providers Streamlined Ordering Of Grail's Galleri® Multi-Cancer Early Detection (Mced) Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781969?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:15","pubTimestamp":1747080935,"startTime":"0","endTime":"0","summary":"BRIEF-Grail And Athenahealth Team Up To Offer Healthcare Providers Streamlined Ordering Of Grail's Galleri Multi-Cancer Early Detection (Mced) TestMay 12 (Reuters) - Grail Inc GRAL.O:GRAIL AND ATHENAH","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535895197","title":"GRAIL Inc. Partners with athenahealth to Streamline Ordering of Galleri Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2535895197","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535895197?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080107,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, has announced a new partnership with athenahealth, a prominent provider of healthcare software solutions. This collaboration aims to integrate the ordering of GRAIL's Galleri multi-cancer early detection  test into athenaCoordinator Core, part of athenahealth's cloud-based electronic health record  system. This integration will enable over 160,000 U.S. clinicians on the athenahealth network to more efficiently order the Galleri test, streamlining the process and reducing administrative burdens. The Galleri test, which screens for multiple cancers through a single blood draw, will help enhance routine exams and improve access to early cancer detection for patients at elevated risk.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL3lh90R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535789332","title":"Grail and Athenahealth Team up to Offer Healthcare Providers Streamlined Ordering of Grail's Galleri® Multi-Cancer Early Detection (Mced) Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789332?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080073,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK2EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2533988974","title":"Legendary investor Bill Miller on why the worst is over for stocks, Amazon's a buy and Tesla isn't","url":"https://stock-news.laohu8.com/highlight/detail?id=2533988974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533988974?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:52","pubTimestamp":1746615120,"startTime":"0","endTime":"0","summary":"Markets have pretty much discounted the worst news, says Bill Miller. Is it time for investors to breathe a bit easier?\"I think the worst is over for the market. I'm pretty confident about that,\" says legendary investor Bill Miller, best known for beating the S&P 500 SPX 15 straight years.He views history as a guide and says no matter what the cause of the selloff, when it comes to what happens next, \"probabilistically you're going to do very, very well if you're in the market,\" he said.\"Probably the best evidence that the Mag 7 will fight another day, except for Tesla, is that Amazon is spending a hundred billion dollars this year to meet customer demand for compute and for chips and for AWS to build data centers,\" he said.\"They're going to have to knock the cover off the ball in terms of self-driving cars and AI,\" he said. \"Tesla's charging $8,000 for their self-driving system and BYD has a self-driving system in a $9,000 car. BYD's cars, I think they're just better.\". He's fan of St","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","NVD3.UK","USAW.SI","LU2083900584.USD","TSYW.SI","TSLA","YOU","TSLL","US30Y.BOND","NVDS","NVD","MLR","NVDX","NVD2.UK","NVDD","IE00BZ1G4Q59.USD","US2Y.BOND","LU1303367103.USD","NVDS.UK","SNVD.UK","LU1718418525.SGD","LU2087625088.SGD","STRK","NVIW.SI","AMZN","LU0070302665.USD","US6M.BOND","3NVD.UK","US5Y.BOND","GRAL","2NVD.UK","NVDU","US10Y.BOND","US3Y.BOND","BTC.USD.HKCC","BK4554","US12M.BOND","LU0127658192.USD","US7Y.BOND","NVDY"],"gpt_icon":1},{"id":"2533666013","title":"SEC to drop investigation of Illumina’s Grail deal, Endpoints News says","url":"https://stock-news.laohu8.com/highlight/detail?id=2533666013","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533666013?lang=en_us&edition=fundamental","pubTime":"2025-05-07 03:05","pubTimestamp":1746558357,"startTime":"0","endTime":"0","summary":"The SEC is expected to drop an investigation into Illumina’s (ILMN) $8B acquisition of cancer test developer Grail (GRAL), reported Endpoints News’...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sec-to-drop-investigation-of-illuminas-grail-deal-endpoints-news-says?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sec-to-drop-investigation-of-illuminas-grail-deal-endpoints-news-says?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4585","ILMN","BK4548","BK4535","BK4139","BK4588","GRAL","BK4121"],"gpt_icon":0},{"id":"2533793594","title":"CFO Aaron Freidin Reports Disposal of Common Shares in Grail Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2533793594","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533793594?lang=en_us&edition=fundamental","pubTime":"2025-05-06 08:47","pubTimestamp":1746492430,"startTime":"0","endTime":"0","summary":"Aaron Freidin, Chief Financial Officer of Grail Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nNDLb5Q7h3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":95,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"GRAL","fiscalQuarterEnding":"2025/03","expectedEps":-4.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.1},{"market":"US","date":"2025-02-20","symbol":"GRAL","fiscalQuarterEnding":"2024/12","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2024-11-12","symbol":"GRAL","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-3.94},{"market":"US","date":"2024-08-13","symbol":"GRAL","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-5.3},{"market":"US","date":"2024-06-25","symbol":"GRAL","reason":null,"defaultRemindTime":1719322200000,"announcedDate":"2024-06-05","type":"delisting","dateTimestamp":1719288000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2025-06-06","current":-0.742094,"percent":0.058559,"low":-0.873079,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"high":-0.135365,"avg":-0.370612,"sd":0.202668,"marketCap":1420593278},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278}],"updateTime":1749438306352}}}